Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations (APIC-II)
Primary Purpose
Hallucinations, Verbal Auditory
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
fMRI
Neurofeedback
PANAS
AVHRS
SF36
Sponsored by
About this trial
This is an interventional treatment trial for Hallucinations, Verbal Auditory focused on measuring fMRI, neurofeedback, hallucination, schizophrenia
Eligibility Criteria
Inclusion Criteria:
- Schizophrenia according to ICD-10 (F2x) with verbal hallucinations or only verbal hallucinations (no psychiatric diagnosis) or healthy subjects without verbal hallucinations
- Fluent German language skills
Exclusion Criteria:
- addiction
- severe affective disorder
- any contraindication to MRI examination or claustrophobia
- pregnant or lactating women
- traumatic brain lesions
- acute physical or neurological impairments
- acute suicidal tendency
- Lack of informed consent
Sites / Locations
- University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
fMRI Neurofeedback up-regulation
fMRI Neurofeedback down-regulation
Arm Description
Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)
Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)
Outcomes
Primary Outcome Measures
change in self-control over neuronal connectivity
fMRI-BCI as a measure before and after the regulation of the brain activity
Secondary Outcome Measures
Changes from baseline in brain plasticity
fMRI as a measure for brain plasticity before and after neurofeedback
Change in pathology (AVH)
Auditory Vocal Hallucinations Rating Scale (AVHRS) as a measure of the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview
number of patients and subjects with benefits from neurofeedback training
change in brain activation
fMRI as a measure before and after the following resting state
Change in pathology (mood)
Positive And Negative Affect Scales (PANAS) as a measure of mood before and after the fMRI and after 1 week during a telephone interview
Change in perceived quality of life
SF36 questionnaire as a measure of the quality of life before and after the fMRI and after 1 week during a telephone interview
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02722915
Brief Title
Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations
Acronym
APIC-II
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
July 2016 (Actual)
Primary Completion Date
December 2019 (Actual)
Study Completion Date
December 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
RWTH Aachen University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is the examination of brain plasticity on verbal auditory hallucinations (AVH) after neuromodulation with fMRI (functional magnetic resonance imaging) neurofeedback. During the training of fMRI neurofeedback subjects are trained to regulate consciously the connectivity of areas which are associated with hallucinations.The aim is to improve perceived hallucinations' intensity in everyday life of the patients as well as investigating the impact of neurofeedback on resting-state networks in the brain. As control groups, control subjects without AVH and participants with AVH, but no psychiatric diagnosis will be included.
Detailed Description
This study investigates the brain plasticity after neuromodulation with fMRI neurofeedback on verbal auditory hallucinations (AVH). The new technique of real-time fMRI enables subjects to influence their brain activity in certain areas based on neurofeedback. Current brain activity as measured by fMRI will be reported to the participants in real time via brain computer interface (BCI). Due to the identification of contingency between feedback and mental strategies subjects are able to control their own brain activity consciously. This provides the opportunity to control symptoms such as AVH. Neurofeedback has been tested on subjects with schizophrenia, leading to conscious control of circumscribed brain areas. Recent studies show that, in addition to the modulation of single areas, neurofeedback can also modulate connectivity between different areas. Thus, it is possible to regulate not only single brain regions but also whole networks.
AVH are a key symptom of schizophrenia. They limit social functions significantly and are resistant to the therapy with antipsychotics in 25 % of cases. AVH also occur in 6-15 % of the healthy population, without meeting any diagnostic criteria for schizophrenia or other psychiatric disorders. This study will perform a direct, not-invasive and selective modulation of networks underlying AVH and assess their neural, cognitive and emotional effects. The focus of this study is on the connectivity between auditory cortex and inferior frontal cortex. Various studies demonstrated that the auditory cortex exhibits an abnormal function in schizophrenia patients. It was shown that during AVH, auditory cortex (superior temporal lobe) and inferior frontal cortex synchronize spontaneously. These regions play an essential role in speech perception and processing. An increased synchronisation of these areas could lead to the development of AVH. This study will try to reduce frontotemporal connectivity to uncouple the regions. Increasing connectivity of both areas will serve as control condition and furthermore intensify the perceived control of the own brain activity and of the associated AVH. Thus, patients will learn which factors influence the appearance of their hallucinations.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hallucinations, Verbal Auditory
Keywords
fMRI, neurofeedback, hallucination, schizophrenia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
81 (Actual)
8. Arms, Groups, and Interventions
Arm Title
fMRI Neurofeedback up-regulation
Arm Type
Experimental
Arm Description
Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)
Arm Title
fMRI Neurofeedback down-regulation
Arm Type
Experimental
Arm Description
Study related procedures included: PANAS, AVHRS, SF 36 (questionnaires or evaluations)
Intervention Type
Procedure
Intervention Name(s)
fMRI
Other Intervention Name(s)
functional magnetic resonance imaging
Intervention Description
collection of functional brain data for 1 hour per day
Intervention Type
Behavioral
Intervention Name(s)
Neurofeedback
Intervention Description
Task of the participants is to increase or decrease the connectivity between selected brain regions in double-blind, randomized order. After the regulation they will get a feedback about the regulation success. (Patients and controls with AVH: days 3 & 4; controls without AVH: Days 2 & 3)
Intervention Type
Other
Intervention Name(s)
PANAS
Other Intervention Name(s)
Positive And Negative Affect Scales
Intervention Description
to assess the mood before and after the fMRI and after 1 week during a telephone interview
Intervention Type
Other
Intervention Name(s)
AVHRS
Other Intervention Name(s)
Auditory Vocal Hallucinations Rating Scale
Intervention Description
to assess the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview
Intervention Type
Other
Intervention Name(s)
SF36
Intervention Description
questionnaire about life quality after 1 week during a telephone interview
Primary Outcome Measure Information:
Title
change in self-control over neuronal connectivity
Description
fMRI-BCI as a measure before and after the regulation of the brain activity
Time Frame
1 week
Secondary Outcome Measure Information:
Title
Changes from baseline in brain plasticity
Description
fMRI as a measure for brain plasticity before and after neurofeedback
Time Frame
2 weeks
Title
Change in pathology (AVH)
Description
Auditory Vocal Hallucinations Rating Scale (AVHRS) as a measure of the intensity and quality of the hallucinations before and after the fMRI and after 1 week during a telephone interview
Time Frame
1 week after interventions
Title
number of patients and subjects with benefits from neurofeedback training
Time Frame
2 weeks
Title
change in brain activation
Description
fMRI as a measure before and after the following resting state
Time Frame
1 week after interventions
Title
Change in pathology (mood)
Description
Positive And Negative Affect Scales (PANAS) as a measure of mood before and after the fMRI and after 1 week during a telephone interview
Time Frame
1 week after interventions
Title
Change in perceived quality of life
Description
SF36 questionnaire as a measure of the quality of life before and after the fMRI and after 1 week during a telephone interview
Time Frame
1 week after interventions
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Schizophrenia according to ICD-10 (F2x) with verbal hallucinations or only verbal hallucinations (no psychiatric diagnosis) or healthy subjects without verbal hallucinations
Fluent German language skills
Exclusion Criteria:
addiction
severe affective disorder
any contraindication to MRI examination or claustrophobia
pregnant or lactating women
traumatic brain lesions
acute physical or neurological impairments
acute suicidal tendency
Lack of informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Klaus Mathiak, Prof MD PhD
Organizational Affiliation
University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics
City
Aachen
ZIP/Postal Code
52074
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations
We'll reach out to this number within 24 hrs